Agency Information Collection Activities; Submission to OMB for Review and Approval; Public Comment Request, 17154-17155 [2014-06765]
Download as PDF
<![CDATA[
17154
Federal Register / Vol. 79, No. 59 / Thursday, March 27, 2014 / Notices
Parties: ZIM Integrated Shipping
Services, Ltd. and Turkon Container
Transportation & Shipping Inc.
Filing Party: Mark E. Newcomb; ZIM
American Integrated Shipping Services
Co., LLC; 5801 Lake Wright Dr.; Norfolk,
VA 23508.
Synopsis: The agreement authorizes
Turkon to charter space to ZIM in the
trade between Greece and the U.S. East
Coast. The parties have requested
expedited review.
By Order of the Federal Maritime
Commission.
Dated: March 21, 2014.
Karen V. Gregory,
Secretary.
Jean
Ellen (202) 434–9950/(202) 708–9300
for TDD Relay/1–800–877–8339 for toll
free.
CONTACT PERSON FOR MORE INFO:
Emogene Johnson,
Administrative Assistant.
[FR Doc. 2014–06904 Filed 3–25–14; 11:15 am]
BILLING CODE 6735–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
[Document Identifier: 201403–0990–004–
30D]
[FR Doc. 2014–06711 Filed 3–26–14; 8:45 am]
BILLING CODE 6730–01–P
FEDERAL MINE SAFETY AND HEALTH
REVIEW COMMISSION
Agency Information Collection
Activities; Submission to OMB for
Review and Approval; Public Comment
Request
ACTION:
Sunshine Act Notice
Office of the Secretary, HHS.
Notice.
AGENCY:
In compliance with section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the
Secretary (OS), Department of Health
and Human Services, has submitted an
Information Collection Request (ICR),
described below, to the Office of
Management and Budget (OMB) for
review and approval. The ICR is for a
new generic clearance for information
collection. Comments submitted during
the first public review of this ICR will
be provided to OMB. OMB will accept
further comments from the public on
this ICR during the review and approval
period.
DATES: Comments on the ICR must be
received on or before April 28, 2014.
ADDRESSES: Submit your comments to
OIRA_submission@omb.eop.gov or via
facsimile to (202) 395–5806.
FOR FURTHER INFORMATION CONTACT:
Information Collection Clearance staff,
Information.CollectionClearance@
hhs.gov or (202) 690–6162.
SUMMARY:
March 24, 2014.
10:00 a.m., Thursday,
April 10, 2014.
PLACE: The Richard V. Backley Hearing
Room, Room 511N, 1331 Pennsylvania
Avenue NW., Washington, DC 20004
(entry from F Street entrance).
STATUS: Open.
MATTERS TO BE CONSIDERED: The
Commission will consider and act upon
the following in open session: Secretary
of Labor v. Wolf Run Mining Co., Docket
Nos. WEVA 2006–853, et al. (Issues
include whether the Administrative
Law Judge erred in concluding that a
violation of a lightning arrester standard
was not ‘‘significant and substantial.’’)
Any person attending this meeting
who requires special accessibility
features and/or auxiliary aids, such as
sign language interpreters, must inform
the Commission in advance of those
needs. Subject to 29 CFR 2706.150(a)(3)
and 2706.160(d).
TIME AND DATE:
When
submitting comments or requesting
information, please include the
Information Collection Request Title
and document identifier 201403–0990–
004–30D for reference.
Information Collection Request Title:
ASPE Generic Clearance for the
Collection of Qualitative Research and
Assessment.
Abstract: The Office of the Assistant
Secretary for Planning and Evaluation at
the Department of Health and Human
Services (HHS) is requesting a generic
clearance for purposes of conducting
qualitative research.
Need and Proposed Use of the
Information: The information collected
will be used to gain a better
understanding of emerging health policy
issues, develop future intramural and
extramural research projects, and to
ensure HHS leadership, agencies and
offices have recent data and information
to inform program and policy decisionmaking.
Likely Respondents: Policy experts,
national, state, and local health
representatives, healthcare providers,
and representatives of other health
organizations.
Burden Statement: Burden in this
context means the time expended by
persons to generate, maintain, retain,
disclose or provide the information
requested. This includes the time
needed to review instructions, to
develop, acquire, install and utilize
technology and systems for the purpose
of collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information, to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information, and to
transmit or otherwise disclose the
information. The total annual burden
hours estimated for this ICR are
summarized in the table below.
SUPPLEMENTARY INFORMATION:
TOTAL ESTIMATED ANNUALIZED BURDEN—HOURS
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
hours
Health Policy Stakeholder ...............................................................................
tkelley on DSK3SPTVN1PROD with NOTICES
Type of
respondent
747
1
1
747
VerDate Mar<15>2010
18:40 Mar 26, 2014
Jkt 232001
PO 00000
Frm 00029
Fmt 4703
Sfmt 9990
E:\FR\FM\27MRN1.SGM
27MRN1
Federal Register / Vol. 79, No. 59 / Thursday, March 27, 2014 / Notices
Keith A. Tucker,
Information Collection Clearance Officer.
[FR Doc. 2014–06765 Filed 3–26–14; 8:45 am]
BILLING CODE 4150–05–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2014–N–0238]
Neurological Devices Panel of the
Medical Devices Advisory Committee;
Notice of Meeting; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
tkelley on DSK3SPTVN1PROD with NOTICES
ACTION:
Notice.
This notice announces a forthcoming
meeting of a public advisory committee
of the Food and Drug Administration
(FDA). The meeting will be open to the
public.
Name of Committee: Neurological
Devices Panel of the Medical Devices
Advisory Committee.
General Function of the Committee:
To provide advice and
recommendations to the Agency on
FDA’s regulatory issues.
Date and Time: The meeting will be
held on April 24, 2014, from 8 a.m. to
6 p.m.
Location: Holiday Inn, Main
Ballroom, 2 Montgomery Village Ave.,
Gaithersburg, MD 20879. The hotel’s
telephone number is 301–948–8900.
Contact Person: Avena Russell, Center
for Devices and Radiological Health,
Food and Drug Administration, 10903
New Hampshire Ave., Bldg. 66, Rm.
1535, Silver Spring, MD 20993–0002,
Avena.Russell@fda.hhs.gov, 301–796–
3805, or FDA Advisory Committee
Information Line, 1–800–741–8138
(301–443–0572 in the Washington, DC
area). A notice in the Federal Register
about last minute modifications that
impact a previously announced
advisory committee meeting cannot
always be published quickly enough to
provide timely notice. Therefore, you
should always check the Agency’s Web
site at https://www.fda.gov/
AdvisoryCommittees/default.htm and
scroll down to the appropriate advisory
committee meeting link, or call the
advisory committee information line to
learn about possible modifications
before coming to the meeting.
Agenda: On April 24, 2014, the
committee will discuss the current
knowledge about the safety and
effectiveness of aversive conditioning
devices that are intended to deliver a
noxious electrical stimulus to a patient
VerDate Mar<15>2010
18:40 Mar 26, 2014
Jkt 232001
to modify undesirable behavioral
characteristics. FDA is convening this
committee to seek clinical and scientific
expert opinion on the risks and benefits
of certain aversive conditioning devices
based on available scientific data and
information. The Agency is considering
whether to ban aversive conditioning
devices that are intended to administer
a noxious electrical stimulus to a patient
to modify undesirable behavioral
characteristics. The meeting will
concern only devices classified under
21 CFR 882.5235 (aversive conditioning
device, class II) that are not selfadministered. Devices which deliver a
noxious electrical stimulus
automatically are not considered to be
self-administered devices. Section 516
of the FD&C Act (21 U.S.C. 360f) sets
forth the standard for banning devices.
Under that provision, in order to ban a
device, FDA must make a finding that
a device ‘‘presents substantial deception
or an unreasonable and substantial risk
of illness or injury’’ based on all
available data and information. FDA
regulations provide additional details
about the procedures and standards for
banning a device (21 CFR part 895).
FDA intends to make background
material available to the public no later
than 2 business days before the meeting.
If FDA is unable to post the background
material on its Web site prior to the
meeting, the background material will
be made publicly available at the
location of the advisory committee
meeting, and the background material
will be posted on FDA’s Web site after
the meeting. Background material is
available at https://www.fda.gov/
AdvisoryCommittees/Calendar/
default.htm. Scroll down to the
appropriate advisory committee meeting
link.
Procedure: FDA will work with
affected industry, professional
organizations, and societies that have an
interest in aversive conditioning devices
and who wish to make a presentation
separate from the general open public
hearing; time slots on April 24, 2014,
between approximately 11 a.m. and 12
p.m. Representatives from industry,
professional organizations and societies
interested in making formal
presentations to the committee should
notify the contact person on or before
March 28, 2014.
Interested persons may present data,
information, or views, orally or in
writing, on issues pending before the
committee. Written submissions may be
made to the contact person on or before
April 14, 2014. Oral presentations from
the public will be scheduled between
approximately 1 p.m. and 2 p.m. Those
individuals interested in making formal
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
17155
oral presentations should notify the
contact person and submit a brief
statement of the general nature of the
evidence or arguments they wish to
present, the names and addresses of
proposed participants, and an
indication of the approximate time
requested to make their presentation on
or before April 4, 2014. Time allotted for
each presentation may be limited. If the
number of registrants requesting to
speak is greater than can be reasonably
accommodated during the scheduled
open public hearing session, FDA may
conduct a lottery to determine the
speakers for the scheduled open public
hearing session. The contact person will
notify interested persons regarding their
request to speak by April 7, 2014.
FDA is opening a docket for public
comment on this document. The docket
number is FDA–2014–N–0238. The
docket will close on June 24, 2014.
Interested persons are encouraged to use
the docket to submit electronic or
written comments regarding this
meeting. Comments received on or
before April 14, 2014, will be provided
to the committee for their consideration.
Comments received after May 27, 2014
will be taken into consideration by the
Agency.
Interested persons may submit either
electronic comments regarding this
document to https://www.regulations.gov
or written comments to the Division of
Dockets Management (see ADDRESSES). It
is only necessary to send one set of
comments. Identify comments with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday, and
will be posted to the docket at https://
www.regulations.gov.
Persons attending FDA’s advisory
committee meetings are advised that the
Agency is not responsible for providing
access to electrical outlets.
FDA welcomes the attendance of the
public at its advisory committee
meetings and will make every effort to
accommodate persons with physical
disabilities or special needs. If you
require special accommodations due to
a disability, please contact AnnMarie
Williams at Annmarie.Williams@
fda.hhs.gov, or 301–796–5966 at least 7
days in advance of the meeting.
FDA is committed to the orderly
conduct of its advisory committee
meetings. Please visit our Web site at
https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm111462.htm for procedures on
public conduct during advisory
committee meetings.
E:\FR\FM\27MRN1.SGM
27MRN1
]]>Agencies
[Federal Register Volume 79, Number 59 (Thursday, March 27, 2014)]
[Notices]
[Pages 17154-17155]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-06765]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Office of the Secretary
[Document Identifier: 201403-0990-004-30D]
Agency Information Collection Activities; Submission to OMB for
Review and Approval; Public Comment Request
AGENCY: Office of the Secretary, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: In compliance with section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the Office of the Secretary (OS), Department of
Health and Human Services, has submitted an Information Collection
Request (ICR), described below, to the Office of Management and Budget
(OMB) for review and approval. The ICR is for a new generic clearance
for information collection. Comments submitted during the first public
review of this ICR will be provided to OMB. OMB will accept further
comments from the public on this ICR during the review and approval
period.
DATES: Comments on the ICR must be received on or before April 28,
2014.
ADDRESSES: Submit your comments to OIRA_submission@omb.eop.gov or via
facsimile to (202) 395-5806.
FOR FURTHER INFORMATION CONTACT: Information Collection Clearance
staff, Information.CollectionClearance@hhs.gov or (202) 690-6162.
SUPPLEMENTARY INFORMATION: When submitting comments or requesting
information, please include the Information Collection Request Title
and document identifier 201403-0990-004-30D for reference.
Information Collection Request Title: ASPE Generic Clearance for
the Collection of Qualitative Research and Assessment.
Abstract: The Office of the Assistant Secretary for Planning and
Evaluation at the Department of Health and Human Services (HHS) is
requesting a generic clearance for purposes of conducting qualitative
research.
Need and Proposed Use of the Information: The information collected
will be used to gain a better understanding of emerging health policy
issues, develop future intramural and extramural research projects, and
to ensure HHS leadership, agencies and offices have recent data and
information to inform program and policy decision-making.
Likely Respondents: Policy experts, national, state, and local
health representatives, healthcare providers, and representatives of
other health organizations.
Burden Statement: Burden in this context means the time expended by
persons to generate, maintain, retain, disclose or provide the
information requested. This includes the time needed to review
instructions, to develop, acquire, install and utilize technology and
systems for the purpose of collecting, validating and verifying
information, processing and maintaining information, and disclosing and
providing information, to train personnel and to be able to respond to
a collection of information, to search data sources, to complete and
review the collection of information, and to transmit or otherwise
disclose the information. The total annual burden hours estimated for
this ICR are summarized in the table below.
Total Estimated Annualized Burden--Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Number of responses per per response Total burden
respondents respondent (in hours) hours
----------------------------------------------------------------------------------------------------------------
Health Policy Stakeholder................... 747 1 1 747
----------------------------------------------------------------------------------------------------------------
[[Page 17155]]
Keith A. Tucker,
Information Collection Clearance Officer.
[FR Doc. 2014-06765 Filed 3-26-14; 8:45 am]
BILLING CODE 4150-05-P
